Search

Your search keyword '"Chang, Ting-Chia"' showing total 185 results

Search Constraints

Start Over You searched for: Author "Chang, Ting-Chia" Remove constraint Author: "Chang, Ting-Chia"
185 results on '"Chang, Ting-Chia"'

Search Results

1. Pharmacodynamic effects of the PARP inhibitor talazoparib (MDV3800, BMN 673) in patients with BRCA-mutated advanced solid tumors

5. Lactiplantibacillus plantarum 1008 Promotes Reproductive Function and Cognitive Activity in Aged Male Mice with High-Fat-Diet-Induced Obesity by Altering Metabolic Parameters and Alleviating Testicular Oxidative Damage, Inflammation and Apoptosis.

6. Lactiplantibacillus plantarum 1008 Enhances Testicular Function and Spermatogenesis via the Modulation of Gut Microbiota in Male Mice with High-Fat-Diet-Induced Obesity.

7. XPF activates break-induced telomere synthesis

8. Molecular profiling of plasma from matched NCI-MATCH gynecological cancers.

9. Assessing the diversity and determinants of health‐related quality of life measures in patients with acute heart failure.

11. High Performance Single Layered WSe2 p-FETs with Chemically Doped Contacts

13. Pharmacodynamic effects of the PARP inhibitor talazoparib (MDV3800, BMN 673) in patients with BRCA-mutated advanced solid tumors

18. Abstract 6072: Chromosomal aneuploidy, whole-genome doubling and mutational signatures in NCI PDMR models

19. Abstract 2050: Molecular subclassification of NCI PDMR breast cancer models using PAM50 gene expression signature

20. Abstract 40: NCI patient derived models repository: PDX, organoid and cell lines from the same patient - bridging the translational pipeline

22. Supplementary Tables S1-S2; Supplementary Figures S1-S4; and Supplementary Materials and Methods from RON Nuclear Translocation under Hypoxia Potentiates Chemoresistance to DNA Double-Strand Break–Inducing Anticancer Drugs

23. Data from Safety, Antitumor Activity, and Biomarker Analysis in a Phase I Trial of the Once-daily Wee1 Inhibitor Adavosertib (AZD1775) in Patients with Advanced Solid Tumors

24. Supplementary Data from Safety, Antitumor Activity, and Biomarker Analysis in a Phase I Trial of the Once-daily Wee1 Inhibitor Adavosertib (AZD1775) in Patients with Advanced Solid Tumors

26. The Application of Augmented Reality to Design Education

31. Abstract 973: Comparative single cell transcriptome profiling of primary tumors, CTCs and metastatic sites from a bladder cancer PDX model

32. Abstract 80: Genomic characterization of PDX models from rare cancer patients in the NCI Patient-Derived Models Repository

33. Abstract 3120: Method development for generation of PDX models from rapid autopsy samples for the NCI patient-derived models repository

34. Abstract 1913: Quality control workflows developed for the NCI Patient-Derived Models Repository using low pass whole genome sequencing and whole exome sequencing

35. Comparison of AYA versus non-AYA ovarian cancer genomic landscape in NCI-MATCH trial.

36. Blood-based detection of actionable alterations from NCI-MATCH patients with no tissue results.

40. Abstract P097: Comparative single cell transcriptome profiling of primary tumors, CTCs and metastatic sites from a bladder cancer PDX model

41. Evaluation of a Rapid Automated Next Generation Sequencing Assay for Precision Medicine in Acute Myeloid Leukemia

42. Risk factors for reintubation and mortality among patients who had unplanned extubation.

45. Abstract 3139: Study of tumor heterogeneity and subclonality in primary pancreatic and metastatic sites from rapid autopsy patients in PDMR

46. Abstract 3012: Patient-derived models of rare cancers in the National Cancer Institute's patient-derived models repository

47. Safety, Antitumor Activity, and Biomarker Analysis in a Phase I Trial of the Once-daily Wee1 Inhibitor Adavosertib (AZD1775) in Patients with Advanced Solid Tumors

Catalog

Books, media, physical & digital resources